cvs caremark tirzepatide is adding Zepbound, Eli Lilly's obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk's Wegovy. MORE tirzepatide cvs caremark CVS Caremark

Tirzepatide works by activating receptors for two hormones: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) These hormones influence: hunger levels insulin sensitivity blood sugar regulation fat storage metabolic efficiency Because tirzepatide affects both appetite and metabolism, many patients experience meaningful reductions in body fat over time

These tests allow the doctor to track how your body is responding, and they can make any necessary changes in dosage or timing if they detect something unusual

This dual-action makes GLP-1 receptor agonists (GLP-1 Ras) a promising treatment strategy for PD

Diabetes Metab Syndr 16(6):102511